Cargando…
TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
Autores principales: | Visaria, Aayush, Hong, Stephanie, Wen, Sijin, Makwana, Priyal, Chapman, Scott, Khodaverdi, Maryam, Singh, Jasvinder, Ogungbe, Oluwabunmi, Neumann, Jacob, Sokos, George G., Patel, Brijesh D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972457/ http://dx.doi.org/10.1016/S0735-1097(22)02941-2 |
Ejemplares similares
-
HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022) -
COVID-19 RELATED OUTCOMES IN PATIENTS WITH PREEXISTING CARDIOVASCULAR DISEASES, WITH OR WITHOUT CANCER
por: Patel, Brijesh D., et al.
Publicado: (2022) -
CARDIOVASCULAR PATIENT OUTCOMES AND COMPLICATIONS AFTER SARS-COV-2 INFECTION
por: Khodaverdi, M., et al.
Publicado: (2022) -
Outcomes of Patients with Active Cancers and Pre-Existing Cardiovascular Diseases Infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023) -
Outcomes of patients with active cancers and pre-existing cardiovascular diseases infected with SARS-CoV-2
por: Patel, Brijesh, et al.
Publicado: (2023)